BNTX ▲ +1.2% - BioNTech SE $BNTX - Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine BioNTech shares rose 1.2% following news that Pfizer and BioNTech received U.S. FDA approval for their XFG-adapted COVID-19 vaccine. The regulatory clearance represents a new product authorization for the companies' COVID-19 vaccine portfolio, which could contribute to future revenue streams. This approval allows the companies to offer an updated vaccine option in the U.S. market. 27-AUG-2026 04:30 PM ET